The decrease in Bcl-2 and increase in Bax confirmed apoptosis in cancer cells, indicating that miR-497/SK-NBs treatment may boost CTL-mediated cytotoxicity through the mitochondrial apoptosis pathway. This evidence concerns the gene BCL2 and cancer.